GNF179
|
G647347-5mg
|
≥99% |
1261114-01-5 |
5mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
GNF179
|
G647347-50mg
|
≥99% |
1261114-01-5 |
50mg
|
¥ 16500.9
|
期货,请咨询 |
阿拉丁 |
GNF179
|
G647347-1mg
|
≥99% |
1261114-01-5 |
1mg
|
¥ 1333.9
|
期货,请咨询 |
阿拉丁 |
GNF179
|
G647347-10mg
|
≥99% |
1261114-01-5 |
10mg
|
¥ 5800.9
|
期货,请咨询 |
阿拉丁 |
GNF179
|
G647347-100mg
|
≥99% |
1261114-01-5 |
100mg
|
¥ 24500.9
|
期货,请咨询 |
阿拉丁 |
GSK2646264
|
G647308-5mg
|
≥98% |
1398695-47-0 |
5mg
|
¥ 8000.9
|
期货,请咨询 |
阿拉丁 |
GSK2646264
|
G647308-10mg
|
≥98% |
1398695-47-0 |
10mg
|
¥ 12800.9
|
期货,请咨询 |
阿拉丁 |
GLPG2451
|
G647307-5mg
|
≥99% |
2055015-61-5 |
5mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
GLPG2451
|
G647307-50mg
|
≥99% |
2055015-61-5 |
50mg
|
¥ 16500.9
|
期货,请咨询 |
阿拉丁 |
GLPG2451
|
G647307-10mg
|
≥99% |
2055015-61-5 |
10mg
|
¥ 5500.9
|
期货,请咨询 |
阿拉丁 |
GLPG2451
|
G647307-100mg
|
≥99% |
2055015-61-5 |
100mg
|
¥ 22500.9
|
期货,请咨询 |
阿拉丁 |
GW284543
|
G647296-5mg
|
≥99% |
790186-68-4 |
5mg
|
¥ 1100.9
|
期货,请咨询 |
阿拉丁 |
GW284543
|
G647296-50mg
|
≥99% |
790186-68-4 |
50mg
|
¥ 6900.9
|
期货,请咨询 |
阿拉丁 |
GW284543
|
G647296-10mg
|
≥99% |
790186-68-4 |
10mg
|
¥ 1990.9
|
期货,请咨询 |
阿拉丁 |
GW284543
|
G647296-100mg
|
≥99% |
790186-68-4 |
100mg
|
¥ 9900.9
|
期货,请咨询 |
阿拉丁 |
Glucocorticoid receptor agonist-1
|
G647290-5mg
|
|
2166375-82-0 |
5mg
|
¥ 6800.9
|
期货,请咨询 |
阿拉丁 |
Glucocorticoid receptor agonist-1
|
G647290-10mg
|
|
2166375-82-0 |
10mg
|
¥ 11000.9
|
期货,请咨询 |
阿拉丁 |
GNE-617 hydrochloride
|
G647284-5mg
|
≥99% |
2070014-99-0 |
5mg
|
¥ 900.9
|
期货,请咨询 |
阿拉丁 |
GNE-617 hydrochloride
|
G647284-50mg
|
≥99% |
2070014-99-0 |
50mg
|
¥ 4500.9
|
期货,请咨询 |
阿拉丁 |
GNE-617 hydrochloride
|
G647284-2mg
|
≥99% |
2070014-99-0 |
2mg
|
¥ 550.9
|
期货,请咨询 |
阿拉丁 |
GNE-617 hydrochloride
|
G647284-10mg
|
≥99% |
2070014-99-0 |
10mg
|
¥ 1500.9
|
期货,请咨询 |
阿拉丁 |
GNE-617 hydrochloride
|
G647284-100mg
|
≥99% |
2070014-99-0 |
100mg
|
¥ 7500.9
|
期货,请咨询 |
阿拉丁 |
GNE-9278
|
G647283-5mg
|
≥99% |
2315311-83-0 |
5mg
|
¥ 1200.9
|
期货,请咨询 |
阿拉丁 |
GNE-9278
|
G647283-50mg
|
≥99% |
2315311-83-0 |
50mg
|
¥ 8100.9
|
期货,请咨询 |
阿拉丁 |